The FY2023-1 SBIR Contract Program solicitation has been posted!
“The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) invite small business concerns (SBCs) to submit research proposals under this Small Business Innovation Research (SBIR) Contract Solicitation.
Please see link above for specific solicitations.
Contract funding is very different from grant funding, and a project needs to be a very (very) good fit to pursue this mechanism.
This solicitation has a receipt date of November 4, 2022 for receipt of proposals.
Wondering if your company could win non-dilutive funding through an SBIR contract? Have questions about understanding the solicitation details? Reach out today and we will connect you with one of our experts!
SBIR Contracts Webinar
Join representatives from the CDC and participating NIH Institutes and Centers on Wednesday, August 24, at 1:00 p.m. ET to learn about:
- HHS Small Business Program contract fundamentals
- Contract opportunities and resources
- Awarding component contract topics
Register here or to watch the replay after August 24th.
THE FOLLOWING RESEARCH TOPICS ARE ANTICIPATED TO BE INCLUDED IN SBIR CONTRACT SOLICITATION PHS-2023-1
NATIONAL INSTITUTES OF HEALTH (NIH)
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS):
Topic 023 – Development of Automated Cell Culture Flask Cleaning Instrument
NATIONAL CANCER INSTITUTE (NCI):
Topic 446 – Development of Senotherapeutic Agents for Cancer Treatment
Topic 447 – Non-invasive Device Technology Research & Development for Chemotherapy-induced Peripheral Neuropathy Management
Topic 448 – Wearable Devices for Dosimetry of Radiopharmaceutical Therapy
Topic 449 – Wearable Technologies to Facilitate Remote Monitoring of Cancer Patients Following Treatment
Topic 450 – Technology Platforms for Circulating Tumor-Macrophage Hybrid Cells
Topic 451 – Rapid and Affordable Point-of-Care HPV Diagnostics for Cervical Cancer Control
Topic 452 – Translation of Novel Cancer-Specific Imaging Agents and Techniques to Mediate Successful Image-Guided Cancer Interventions
Topic 453 – Digital Tools to Integrate Cancer Prevention Within Primary Care
Topic 454 – Software to Evaluate Artificial Intelligence/Machine Learning Medical Devices in Oncology Settings
NATIONAL INSTITUTE ON AGING (NIA):
Topic 007 – High Throughput CHIP (clonal hematopoeisis of indeterminate potential) Assay as a Powerful Tool to Study CHIP Related Age Associated Diseases
Topic 008 – Improving Microphysiological Systems for AD/ADRD Therapy Development
Topic 009 – AI/ML Tool for Visualizing Behavioral and Social Science Research
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID):
Topic 113 – Development of a Simian Immunodeficiency Virus (SIV) and Simian Human Immunodeficiency Virus (SHIV) Database
Topic 114 – Point-of-Care HIV Viral Load, Drug Resistance, and Adherence Assays
Topic 115 – Development of Diagnostics to Differentiate HIV Infection from Vaccine-Induced Seropositivity
Topic 116 – Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated Diseases
Topic 117 – Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases
Topic 118 – Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models
Topic 119 – Adaptation of CRISPR-based in vitro Diagnostics for Rapid Detection of Select Eukaryotic Pathogens
Topic 120 – Modular Sample Preparation for In-Field Viral Discovery
Topic 121 – Artificial Intelligence to Improve Clinical Microscopy for Diagnosis of Infectious Diseases
Topic 122 – Advanced and Immersive Visualization Tools for Infectious and Immune-mediated Disease Research
Topic 123 – Data Science Tools for Infectious and Immune-mediated Disease Research
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI):
Topic 113 – Clinical Instrument for Para-Hydrogen (pH2) Based Signal Amplification by Reversible Exchange (SABRE) for Hyperpolarizing 13C-Pyruvate and Other Probes for MRI Imaging
Topic 114 – Device to Permit Continuous Self-Monitoring of Blood Oxygen Saturation During Activities of Daily Living for Individuals at Risk for Desaturation During Physical Exertion
NATIONAL INSTITUTE ON DRUG ABUSE (NIDA):
Topic 167 – Cause of Death Elucidated (CODE) in Drug Overdose: Research and Development of New Postmortem Toxicology Screening Devices that are Portable, Rapid, Accurate, Affordable, and Accessible
CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
NATIONAL CENTER FOR EMERGING ZOONOTIC AND INFECTIOUS DISEASE (NCEZID):
Topic 030 – Developing an Over-the-Counter Diagnostic Test for Valley Fever
NATIONAL CENTER FOR HIV/AIDS, VIRAL HEPATITIS, STD, AND TB PREVENTION (NCHHSTP):
Topic 054 – School Illness-Related Absenteeism and Learning Modality Surveillance
NCI Webinar will be scheduled for Aug 9, 2022. Register here.
Are you ready to get started on winning the non-dilutive funding your company needs?
Recent Comments